Linda J Harrison

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

Katharine J. Bar, Michael C. Sneller, Linda J Harrison et al. · New England Journal of Medicine · 2016 · 475 citations · Full text

Pharmacy, Immunology, Infectious Diseases +13

Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study

Alberto M. La Rosa, Linda J Harrison, Babafemi Taiwo et al. · The Lancet HIV · 2016 · 73 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +9

HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom

Daniella Chilton, Hannah Castro, Sam Lattimore et al. · Antiviral Therapy · 2010 · 20 citations · Full text

Public Health, Infectious Disease Control, Epidemiologic Methods +16

Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women

Thiago S. Torres, Linda J Harrison, Alberto M. La Rosa et al. · AIDS · 2018 · 17 citations · Full text

Pharmacy, Health Sciences, Pharmacotherapy +8

CCR5-Δ32 Heterozygosity, HIV-1 Reservoir Size, and Lymphocyte Activation in Individuals Receiving Long-term Suppressive Antiretroviral Therapy

Timothy J. Henrich, Emily Hanhauser, Linda J Harrison et al. · The Journal of Infectious Diseases · 2015 · 13 citations · Full text

Life Sciences, Immunology, Molecular Genetics +11